(Q48436379)

11 February 2018

title

Primary central nervous system lymphoma: age and performance status are more important than treatment modality. (English)

1 reference

11 February 2018

central nervous system lymphoma

main subject

1 reference

primary central nervous system lymphoma

inferred from title

1 reference

Corry J

1

1 reference

11 February 2018

Smith JG

2

1 reference

11 February 2018

Wirth A

3

1 reference

11 February 2018

Quong G

4

1 reference

11 February 2018

Liew KH

5

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

11 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

11 February 2018

volume

41

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

615-620

1 reference

11 February 2018

Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Radiation therapy in the management of primary malignant lymphoma of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Combined modality therapy for primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Primary lymphoma of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Radiation therapy in primary non-Hodgkin's lymphomas of the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Radiation therapy of microgliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

Primary lymphoma of the central nervous system. An unresolved therapeutic problem

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900571-3

7 January 2021

10.1016/S0360-3016(97)00571-3

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9635710

1 reference

11 February 2018